Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Prolactin for Lactation Induction
NCT00181649Phase 2Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2006
- Primary completion
- May 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Agalactia comparing Recombinant human prolactin with Placebo (2 arms). Primary endpoint: Breast milk production at 28 days. Planned start Sep 2006; status: withdrawn.
02
Drugs
recombinant human prolactin
03
Conditions
Agalactia
Beyond the preview
Go deeper on NCT00181649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181649.